Author(s):
Tabish Ahmed, S. B. Kaikade
Email(s):
dr.tabishahmed@gmail.com
DOI:
10.52711/2321-5836.2024.00011
Address:
Tabish Ahmed1*, S. B. Kaikade2
1Associate Professor, Department of Pharmacology, BRLSABVM GMC Rajnandgaon, Chhattisgarh.
2Professor, Department of Pharmacology, Dr. N Y Tasgaonkar Institute of Medical Sciences, Karjat, Maharashtra.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2024
ABSTRACT:
The National Pharmacovigilance Programme is coordinated by the Indian Pharmacopoeia Commission at Ghaziabad. The Pharmacovigilance Programme of India (PvPI) is now in full swing. We have a network of some 90 adverse drug reaction (ADR) Monitoring Centres (AMCs) across the country. The programme provides financial, logistic and technical support to the AMCs. Initially, only health professionals could report the ADR. Recently PvPI has included all people who consume medicine and not just health professionals, to report ADR. A toll free consumer helpline (1800 180 3024 operational on weekdays during office hours) and a dedicated email address (PvPI.compat@gmail.com) have been launched to encourage people to report ADRs. Aim and objectives: To study awareness and attitude of medicine consumers towards ADR reporting Materials and methods: This is a questionnaire based study where consumers will be given the questionnaire regarding ADRs and their reporting. Study plan: Time duration - 3months. Discussion: It is important to spread awareness and importance about ADR reporting amongst the general population.
Cite this article:
Tabish Ahmed, S. B. Kaikade. Awareness and Attitude of Medicine Consumers towards ADR Reporting: A Questionnaire based study of Rural Chhattisgarh. Research Journal of Pharmacology and Pharmacodynamics. 2024;16(1):58-1. doi: 10.52711/2321-5836.2024.00011
Cite(Electronic):
Tabish Ahmed, S. B. Kaikade. Awareness and Attitude of Medicine Consumers towards ADR Reporting: A Questionnaire based study of Rural Chhattisgarh. Research Journal of Pharmacology and Pharmacodynamics. 2024;16(1):58-1. doi: 10.52711/2321-5836.2024.00011 Available on: https://rjppd.org/AbstractView.aspx?PID=2024-16-1-11
REFERENCES:
1. Preeti S, Manju A, Rajesh Hr et al. Adverse drug reactions at adverse drug reaction monitoring center in Raipur:Analysis of spontaneous reports for 1 year. Indian Journal of Pharmacology. 2017.
2. Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother. 2012; 46(2): 169-75
3. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions:a systematic review of prospective observational studies. Ann Pharmacother. 2008; 42(7): 1017-25
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies. JAMA. 1998; 279(15): 1200-5
5. World Health Organization. Medicines safety, 2017.Available at http://www.who.int/medicines/regulation/medicines-safety/en/(Accessed on 1 October 2017).
6. WHO collaborating centre for International Drug Monitoring; 2018. Available at:http://www.who-umc.org/global-pharmacovigilance/ who-programme/.Accessed on 10 July 2018.
7. Singh GN, Gupta SK et al. Guidance Document for Spontaneous Adverse Drug Reaction Reporting Version:1.0.Indian Pharmacopoeia Commission National Coordination Centre-Pharmacovigilance Programme of India Ministry of Health and family welfare Government of India.12 May 2014.
8. Kalaivani M, Kalaiselvan V, Dabhi K, Singh GN. Direct consumer reporting of ADRs to PVPI, a position paper of Indian Pharmacopoeia Commission .Advances in Pharmacoepidemiology and Drug Safety. 2015; 4(184): 2167-1052
9. Mukherjee S, Sen S, Kalaisevan V, Tripathi S.Consumer reporting of adverse drug reactions:A current perspective. Intern J Green Pharmacy. 2016; 10(3): 136-42
10. Medawar C, Herxheimer A.A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and surgical behaviour with paroxetine.Intern J Risk & Safety in Med. 2003; 16(5): 19
11. Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, 2017.Available at:http://ipc.gov.in. (Accessed on 11 October 2017)
12. Catherine P, Christian L, Sefarina C, et al, Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports. Journal of Pharmacology and Pharmacotherapeutics. 2013; 4(1): 66-72
13. Gupta SK, Nayak RP, Shivrajani R, Vidhyarthi SK.A questionnaire study on knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a teaching hospital in southern India. Perspect. Clin Res. 2015; 6(1): 45-52
14. Jha N, Ratthore DS, Shankar PR, Gywali S. Pharmacovigilance knowledge among patients in teaching hospital in Lalitpur district, Nepal.J Clin Diag Res 2014; 8(3):32-4
15. Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: Knowledge, attitude and practices of medical students and prescribers. Natl India. 2002; 15: 24-6
16. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions:a review of published literature and international experience. Br J Clin Pharmacol. 2007; 63: 148-56.
17. Van Hunsel F, Passier A, Van Groothest K.Comparing patients and healthcare professionals ADR reports after media attention:the broadcast of a Dutch television programme about the benefits and risks of statins as an example.Br J Clin Pharmacol. 2009; 67: 558-64.
18. Pahuja R, Shrivastava B, Sharma P, Kishore K, Mahajan S, Sood R. Awareness on Adverse Drug reaction Reporting System in India:A consumer Survey. American J Phytomedicine and Clin Therap. 2014; 2(12): 1361-9.